Driving value in phase IIIb & IV trials
Ms. Kushner’s professional research career has almost exclusively been in the area of late phase development. Following her nursing training, she joined the pharmaceutical industry as a Clinical Data Coordinator and enjoyed a variety of management positions in the late …more ›
Vipin Arora has over 17 years of Pharmaceutical Industry experience as lead Statistician, Manager, Group Head and Director in Analytical Sciences. Vipin has experience in developing strategies, in-licensing and out-licensing, pre-submission and follow up activities wit…more ›
Dr. Niemcryk is Head, Global Surveillance & Pharmacoepidemiology at Abbott Laboratories. With over 14 years in industry, he has also held positions at Bristol-Myers Squibb, AstraZeneca, and Bayer. Most of his industry experience has been directly in drug safety. Pri…more ›
Dr. Maria Madison has been working in health research since 1983, when she began investigating tropical diseases and health care in rural Zaire. Since then she has worked in industry, government and CROs on a variety of therapeutic areas globally, including infectious,…more ›
Benchmark your late phase strategy alongside the industry's best
Come to Late Phase Drug Development World and learn:
• How to build cost-effective, non-interventional studies
• How to effectively collect, validate & analyze observational data
• How to gain market access globally based on late phase data
• How to turn insight from the real world into a commercial asset
Pharma/biotech delegates- REGISTER NOW FOR A 50% discount!
Sponsors
Late Phase Drug Development World focuses on:
• Strategic challenges in late phase trials
• Pipeline lifecycle management
• Planning for phase IIIb/IV
• Analyzing and interpreting observational studies
• Patient registries
• Benefit/risk management
Pharma/biotech delegates- REGISTER NOW FOR A 50% discount!
Leading global and niche CROs attend:
- To showcase their expertise in late phase drug development
- To position their brand as leaders in late phase drug development
- To showcase solutions in phase IIIb/IV trials
- To generate leads and new business
Who should attend:
Senior Directors & Heads in the following departments:
- Risk Management
- Clinical Trials
- Clinical Research
- Post Marketing Surveillance
- Medical Affairs
- Pharmacoepidemiology
- Investigator Sponsored Studies
- Clinical Data Management
- Clinical Trial Registration
- Results Databases
- Drug Development
- Pharmacovigilance
Who should sponsor:
- CROs
- Technology providers
There are limited sponsorship opportunities available so contact us as soon as possible for more information.
